Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2014; 20(4): 877-887
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.877
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.877
Stage 0 | Tis | N0 | M0 |
Stage I | T1, T2 | N0 | M0 |
Stage II | T3, T4 | N0 | M0 |
Stage IIA | T3 | N0 | M0 |
Stage IIB | T4a | N0 | M0 |
Stage IIC | T4b | N0 | M0 |
Stage III | Any T | N1, N2 | M0 |
Stage IIIA | T1, T2 | N1 | M0 |
T1 | N2a | M0 | |
Stage IIIB | T3, T4a | N1 | M0 |
T2, T3 | N2a | M0 | |
T1, T2 | N2b | M0 | |
Stage IIIC | T4a | N2a | M0 |
T3, T4a | N2b | M0 | |
T4b | N1, N2 | M0 | |
Stage IVA | Any T | any N | M1a |
Stage IVB | Any T | any N | M1b |
- Citation: Damin DC, Lazzaron AR. Evolving treatment strategies for colorectal cancer: A critical review of current therapeutic options. World J Gastroenterol 2014; 20(4): 877-887
- URL: https://www.wjgnet.com/1007-9327/full/v20/i4/877.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i4.877